Approval · Notice of Compliance 36516 · 2025
ZYKADIA: Notice of Compliance 36516
Issued December 10, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36516
- Date
- December 10, 2025
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Fulfillment of commitment(s) [commitments # 1 and #2] of the LOU dated [March 20-2015], issued under (S)NDS control # [175702]
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZYKADIA | Not yet assigned | — |
Medicinal ingredients
- CERITINIB 150 MG per CAP